NCT06336954 2024-03-29Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor FailureSecond Affiliated Hospital of Xi'an Jiaotong UniversityPhase 2 Not yet recruiting40 enrolled